First published at 19:03 UTC on February 11th, 2022.
Belgium exhibits extremely high % of severe adverse reactions compared to the other European countries.
The hypothesis being put forward here is that Belgium is the site for the finishing plant for all European vaccines, so the people of Belgium re…
MORE
Belgium exhibits extremely high % of severe adverse reactions compared to the other European countries.
The hypothesis being put forward here is that Belgium is the site for the finishing plant for all European vaccines, so the people of Belgium receive the vaccine batches first after manufacture.
The mRNA in the vaccines seems to degrade quickly over the first 30 days, and there is a corresponding decrease in toxicity over that period. The % of reports that are severe is three times higher for vaccine deployed within that 30 day window.
So, in consequence, the people of Belgium are receiving the vaccines first, possibly even within the 30 day window, and suffering the consequences.
This is one of those instances where its good to be last - or at least as far past the expiry date as is possible.
LESS